Your browser is no longer supported. Please, upgrade your browser.
GENE Genetic Technologies Limited weekly Stock Chart
GENE [NASD]
Genetic Technologies Limited
Index- P/E- EPS (ttm)-0.44 Insider Own86.50% Shs Outstand12.02M Perf Week18.72%
Market Cap28.51M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float6.08M Perf Month16.71%
Income-4.10M PEG- EPS next Q- Inst Own2.00% Short Float1.22% Perf Quarter49.69%
Sales- P/S- EPS this Y-9.60% Inst Trans15.64% Short Ratio0.05 Perf Half Y18.25%
Book/sh0.36 P/B6.69 EPS next Y- ROA-133.00% Target Price- Perf Year-4.37%
Cash/sh0.19 P/C12.40 EPS next 5Y- ROE-192.50% 52W Range1.41 - 5.36 Perf YTD21.10%
Dividend- P/FCF- EPS past 5Y49.70% ROI- 52W High-58.40% Beta2.54
Dividend %- Quick Ratio2.90 Sales past 5Y- Gross Margin- 52W Low58.35% ATR0.18
Employees64 Current Ratio3.00 Sales Q/Q-96.80% Oper. Margin- RSI (14)51.03 Volatility11.77% 7.99%
OptionableNo Debt/Eq0.15 EPS Q/Q41.50% Profit Margin- Rel Volume0.45 Prev Close2.41
ShortableYes LT Debt/Eq0.05 Earnings- Payout- Avg Volume1.49M Price2.23
Recom- SMA203.05% SMA503.78% SMA200-5.81% Volume670,925 Change-7.47%
Jun-23-20 08:00AM  
Jun-18-20 08:00AM  
Jun-04-20 04:49PM  
May-28-20 09:00PM  
May-26-20 09:22AM  
May-22-20 04:05PM  
May-20-20 09:15AM  
Apr-23-20 08:00AM  
Apr-20-20 08:00AM  
Apr-17-20 08:00AM  
Apr-06-20 06:00AM  
Apr-01-20 12:45PM  
09:00AM  
Mar-13-20 08:15PM  
Mar-12-20 07:35PM  
Jan-13-20 09:00AM  
Jan-07-20 11:45AM  
Jan-06-20 11:24PM  
Dec-17-19 09:00AM  
Dec-10-19 07:00AM  
Nov-15-19 08:30AM  
Nov-05-19 07:00AM  
May-22-19 03:11PM  
May-17-19 01:30PM  
May-10-19 08:10AM  
May-03-19 08:45AM  
Apr-15-19 09:00AM  
Apr-11-19 09:15AM  
Feb-01-19 05:30AM  
Dec-21-18 05:30AM  
Dec-20-18 06:04PM  
Sep-17-18 05:30AM  
Aug-21-18 05:30AM  
Aug-16-18 05:30AM  
Aug-08-18 05:30AM  
Aug-02-18 06:00AM  
Jul-30-18 06:00AM  
Jul-17-18 08:10AM  
Jul-16-18 09:26AM  
05:30AM  
Jun-19-18 05:30AM  
Jun-07-18 05:30AM  
May-30-18 06:00AM  
May-01-18 05:30AM  
Mar-20-18 11:13AM  
11:13AM  
Mar-16-18 05:00AM  
Mar-06-18 09:14AM  
05:30AM  
Feb-15-18 05:00AM  
Feb-12-18 05:00AM  
Feb-06-18 05:00AM  
Feb-05-18 05:00AM  
Jan-31-18 05:00AM  
Jan-30-18 05:00AM  
Jan-29-18 05:30AM  
Jan-09-18 09:11AM  
Oct-05-17 08:10AM  
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. The company also engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. In addition, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia.